theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hematologic Malignancies

Rheumatoid Arthritis   

Questions discussed in this category


When do you recommend initiation of targeted therapies in active RA with history of malignancy?
What is your most and least preferred? In case of cancer in remission and in case of non-remission?
1 Answer available

How would you approach treating patients with RA refractory to cDMARDs and a prior history of MALT lymphoma?
1 Answer available

How do you approach treatment of rheumatoid arthritis in a patient with an active hematologic malignancy (such as leukemia or lymphoma) after methotrexate failure?
Does your management change if there is renal involvement of the malignancy? 
2 Answers available

How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available
209251241391278485


Papers discussed in this category


JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

Arthritis Care Res (Hoboken), 2021 Jul
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Related Topics in Hematologic Malignancies

  • Breast Cancer
  • Head and Neck Cancers
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Pediatric Hematology/Oncology
  • Sarcoma

Copyright © 2025 theMednet
All Rights Reserved.